Tower Research Capital (TRC)’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
Tower Research Capital (TRC)'s BNR Position: Q3 2026 in Review
Tower Research Capital (TRC) sold out of Burning Rock Biotech (BNR) in Q3 2026, closing a stake of 1,242 shares — an estimated $10.4K sold.
Tower Research Capital (TRC) first reported a position in BNR in Q2 2021 and held it in 13 quarters. The position peaked at $28K in Q4 2022. 17 funds tracked by Wall St. Rank hold BNR as of Q3 2026.
- Tower Research Capital (TRC) reported no remaining Burning Rock Biotech position as of Q3 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,242 Burning Rock Biotech shares in Q3 2026, an estimated $10.4K.
- Tower Research Capital (TRC) first reported a position in Burning Rock Biotech in Q2 2021 and held it in 13 quarters.
- Tower Research Capital (TRC)'s Burning Rock Biotech position peaked at $28K in Q4 2022.
- 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.